|
|
OncLive® is excited to return to hybrid events. We are particularly excited to be in attendance with our partners at PER® this coming Saturday, June 19th, at ASCO Direct Highlights™ in Dallas, TX.
|
|
We encourage you to register and attend to learn from leading experts about important, potentially practice-changing data in oncology and hematology.
|
|
|
|
If you can attend in-person on June 19th, we have a special announcement for you! OncLive® will raffle off an Apple iPad during the last break session of this exciting 1-day event. Be sure to visit the OncLive® booth after you check-in to enter for your chance to win. To learn more, see our Official Rules. |
|
|
|
We hope you can join us, either virtually or in-person, for ASCO Direct Highlights on June 19th, where program Co-Chairs Thomas E. Hutton, DO, PharmD, FACP and Joyce O’Shaughnessy, MD will share key practice-changing data.
|
|
|
Thomas E. Hutson, DO, PharmD, FACP
Director, GU Oncology Program
Co-Chair, Urologic Cancer Research and Treatment Center
Texas Oncology
Charles A. Sammons Cancer Center
Baylor University Medical Center
Professor of Medicine
Texas A&M HSC College of Medicine
|
|
Joyce O’Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Director, Breast Cancer Research Program
Texas Oncology
The US Oncology Network
Dallas, TX
|
|
|
|
We know the last year-plus has been difficult being apart and we are excited to see you again. Your health and safety is of utmost importance to us. Please review our MJH Safe Commitment at the bottom of this email to better understand the safety precautions that will be in-place at this and all future in-person events.
|
|
We look forward to being Your Link to Everything Oncology.
|
|
|
SAFETY PRECAUTIONS/PERSONAL ACCOUNTABILITY COMMITMENT
|
|
By attending this program, you agree to abide by and engage in certain health- and safety beneficial conduct while attending the event, including providing proof at check-in of being 2 weeks removed from receiving a full COVID-19 vaccination or results from a negative COVID-19 viral test taken no more than 3 days before the program. For information on the specific safety precautions that will be in place, please visit www.mjhlifesciences.com/mjhsafe and click on Health & Safety Precautions. |
|
|
|
|
|